Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients
- 2 July 2002
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 40 (2), 311-317
- https://doi.org/10.1016/s0735-1097(02)01943-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prognostic Importance of Elevated Jugular Venous Pressure and a Third Heart Sound in Patients with Heart FailureThe New England Journal of Medicine, 2001
- Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunctionJournal of the American College of Cardiology, 2001
- A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart FailureThe New England Journal of Medicine, 2001
- Racial Profiling in Medical ResearchThe New England Journal of Medicine, 2001
- Lesser Response to Angiotensin-Converting–Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular DysfunctionThe New England Journal of Medicine, 2001
- Heart failure in African Americans: A cardiovascular enigmaJournal of Cardiac Failure, 2000
- Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trialsJournal of Cardiac Failure, 1999
- Racial Differences in the Outcome of Left Ventricular DysfunctionThe New England Journal of Medicine, 1999
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsThe New England Journal of Medicine, 1992
- Studies of Left Ventricular Dysfunction (SOLVD)—Rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fractionThe American Journal of Cardiology, 1990